<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="979">
  <stage>Registered</stage>
  <submitdate>17/11/2005</submitdate>
  <approvaldate>17/11/2005</approvaldate>
  <nctid>NCT00256048</nctid>
  <trial_identification>
    <studytitle>Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients.</studytitle>
    <scientifictitle>Efficacy of Nasojejunal Enteral Feeding in Critically Ill Patients.</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>2002.228</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Critically Ill</healthcondition>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Nasojejunal feeding

No Intervention: Standard Care - Patients will receive enteral nutrition via a nasogastric tube as per standard feeding regime

Active Comparator: Nasojejunal Arm - Patient will receive feeding via a nasojejunal feeding tube


Treatment: surgery: Nasojejunal feeding


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Efficacy of feeding</outcome>
      <timepoint>participants will be followed until death, discharge from ICU, commencement of oral or parental nutrition or 28 days post ICU admission</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>1. To determine the incidence of complications with enteral feeding via nasogastric and nasojejunal routes.</outcome>
      <timepoint>participants will be followed until death, discharge from ICU, commencement of parental or oral nutrition or 28 days post ICU admission.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>2. To assess the efficacy of current strategies for optimising enteral feeding efficacy.</outcome>
      <timepoint>participants will be followed until death, discharge from ICU commencement of oral or parental nutrition,or 28 days post ICU admission.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>1. Adult patients (18years or over) admitted to the ICU with an expected stay of more
             than 48 hours.

          2. Patients commenced on enteral feeding via a nasogastric tube who fail to tolerate
             gastric feeding due to excessive gastric aspirate volumes.

          3. Patients who consent or if the patient is incompetent, the next of kin, who consent,
             to inclusion in the study.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. patients less than 18 years of age.

          2. Patients with known allergy to promotility agents, metoclopramide or erythromycin.

          3. Patients with a contra indication to nasojejunal feeding. -</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/05/2003</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize>50</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate>1/07/2005</actuallastvisitdate>
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Intensive Care Unit, Royal Melbourne Hospital, Grattan Street - Parkville</hospital>
    <postcode>3050 - Parkville</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Melbourne Health</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to determine if naso-jejunal feeding (feeding beyond the
      stomach) improves the efficacy of enteral feeding (feeding into the gut) in critically ill
      patients.

      The study hypothesis is that in patients who fail to establish enteral feeding via the
      nasogastric route, introduction of nasojejunal feeding will lead to more effective enteral
      feeding than the current regime involving staged introduction of promotility agents.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00256048</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Megan Robertson</name>
      <address>Intensive Care Unit, Royal Melbourne Hospital</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>